Sponsor or institution
Clinical trials and research at Sparian Biosciences, INC.
As of November 12, 2026, Find a Trial lists 1 clinical trial run by Sparian Biosciences, INC. that is recruiting, in United States. By phase: Phase 1 (1). There are also 5 NIH-funded research projects at this institution, with $19.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 1Clinical trials
- 5NIH research projects
- 1Country
All recruiting trials (1)
-
Phase 1 testing of SBS-147 in healthy adults
This study will test if SBS-147 is safe and how healthy adults' bodies handle single or repeated doses compared with a placebo.
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
First-in-class, non-opioid pain medicine (SBS-147) for acute and chronic pain
A new non-opioid pill called SBS-147 may help adults manage acute and chronic pain with less risk of dependence or overdose.
-
SBS-226: a new medication that activates one opioid receptor and blocks another to treat opioid addiction
This project develops SBS-226, a potential medicine designed to reduce opioid cravings and withdrawal by activating the mu-opioid receptor while blocking the delta-opioid receptor for people with opioid use disorder.
-
Developing a new treatment for opioid use disorder
This study is testing a new medication called SBS-226 to help people with opioid use disorder by providing pain relief without the same risk of addiction that comes with regular opioids.
-
Creating new treatments for stimulant use disorder
This study is testing a new medication called SBS-518 that aims to help people struggling with stimulant use disorder, like those using methamphetamine or cocaine, by reducing their cravings without giving them a high, and there may be chances for patients to join early trials as the research moves forward.
-
A new class of safer pain relievers
This study is testing a new type of pain relief medication called MP1000, which aims to help people manage pain without the risks of addiction that come with traditional opioids.
Quick answers
How many clinical trials run by Sparian Biosciences, INC. are recruiting right now?
1, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.